Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • AML with mutations in IDH1 and DNMT3A exhibits a distinct epigenetic signature with poorer overall survival
    Meeting Abstract

    Ahr, K.; Famulare, C.; Koche, R.; Spitzer, B.; Levine, R. L.; Tallman, M. S.; Goldberg, A. D.; Stein, E. M.; Glass, J. L.
    Blood (2018)

    Fulltext@MSK | Save
  • Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis
    Meeting Abstract

    Bolton, K.; Ptashkin, R.; Braunstein, L.; Kelly, D.; Devlin, S. M.; Coombs, C. C.; Moarii, M.; Patel, M.; Bernard, E.; Berthon, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Results of SWOG 1318: A phase 2 trial of blinatumomab followed by POMP (prednisone, vincristine, methotrexate, 6-mercaptopurine) maintenance in elderly patients with newly diagnosed Philadelphia chromosome negative B-cell acute lymphoblastic leukemia
    Meeting Abstract

    Advani, A. S.; Moseley, A.; O'Dwyer, K. M.; Wood, B.; Fang, M.; Wieduwilt, M. J.; Aldoss, I.; Park, J. H.; Klisovic, R.; Baer, M. R.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Targeting the CALR interactome in myeloproliferative neoplasms
    Journal Article

    Pronier, E.; Cifani, P.; Merlinsky, T. R.; Berman, K. B.; Somasundara, A. V. H.; Rampal, R. K.; LaCava, J.; Wei, K. E.; Pastore, F.; Maag, J. L. V.; more...
    JCI Insight (2018)

    Fulltext@MSK | Save
  • Emerging real-world midostaurin treatment patterns and outcomes in FLT3-mutated acute myeloid leukemia at a comprehensive cancer center
    Meeting Abstract

    Willis, C.; Menon, J.; Unni, S.; Au, T.; Ndife, B.; Joseph, G. J.; Bonifacio, G. J.; Stein, E. M.; Tantravahi, S. K.; Shami, P. J.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • The significance of leukocytosis in malignancies: A novel paradigm between leukocytosis, G-CSF, myeloid-derived suppressor cells and prognosis
    Meeting Abstract

    Tavakkoli, M.; Wilkins, C.; Mones, J. V.; Mauro, M. J.
    Blood (2018)

    Fulltext@MSK | Save
  • Updated 18-month results from DASFREE: A study evaluating dasatinib discontinuation in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) and deep molecular response (DMR)
    Meeting Abstract

    Shah, N. P.; Gutiérrez, J. V. G.; Jiménez-Velasco, A.; Larson, S.; Saussele, S.; Rea, D.; Mahon, F. X.; Levy, M. Y.; Gómez-Casares, M. T.; Pane, F.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Intestinal microbiota composition prior to CAR T cell infusion correlates with efficacy and toxicity
    Meeting Abstract

    Smith, M.; Littmann, E. R.; Slingerland, J. B.; Clurman, A.; Slingerland, A. E.; Taur, Y.; Schluter, J.; Park, J. H.; O'Cearbhaill, R.; Mailankody, S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Efficacy of combined ruxolitinib and decitabine in patients with accelerated and blast-phase myeloproliferative neoplasms: Results of a phase II study (MPN-RC109 trial)
    Meeting Abstract

    Rampal, R. K.; Mascarenhas, J.; Kosiorek, H. E.; Bhave, R.; Hexner, E. O.; Wang, E. S.; Gerds, A. T.; Heaney, M. L.; Abboud, C. N.; Kremyanskaya, M.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Characteristics and outcomes of ibrutinib-associated musculoskeletal toxities in CLL patients
    Meeting Abstract

    Rhodes, J.; Mato, A. R.; Winchell, N.; Kennard, K.; Gerson, J. N.; Landsburg, D. J.; Nasta, S. D.; Svoboda, J.; Schuster, S. J.
    Blood (2018)

    Fulltext@MSK | Save